Abstract
The aim of this study was to develop a taste-masked oral disintegrating film (ODF) containing donepezil, with fast disintegration time and suitable mechanical strength, for the treatment of Alzheimer’s disease. Hydroxypropyl methylcellulose, corn starch, polyethylene glycol, lactose monohydrate and crosspovidone served as the hydrophilic polymeric bases of the ODF. The uniformity, in vitro disintegration time, drug release and the folding endurance of the ODF were examined. The in vitro results showed that 80% of donepezil hydrochloride was released within 5 minutes with mean disintegration time of 44 seconds. The result of the film flexibility test showed that the number of folding time to crack the film was 40 times, an indication of sufficient mechanical property for patient use. A single-dose, fasting, four-period, eight-treatment, double-blind study involving 16 healthy adult volunteers was performed to evaluate the in situ disintegration time and palatability of ODF. Five parameters, namely taste, aftertaste, mouthfeel, ease of handling and acceptance were evaluated. The mean in situ disintegration time of ODF was 49 seconds. ODF containing 7 mg of sucralose were more superior than saccharin and aspartame in terms of taste, aftertaste, mouthfeel and acceptance. Furthermore, the ODF was stable for at least 6 months when stored at 40°C and 75% relative humidity.
Similar content being viewed by others
REFERENCES
Joseph TD, Robert LT, Gary CY, Gary RM, Barbara GW, Michael LP. Pharmacotherapy: a pathophysiologic approach. 6th ed. New York: McGraw Hill; 2005. p. 2162–87.
Martin RF. Effective pharmacologic management of Alzheimer disease. AJM. 2007;120:388–97.
Hanawa T. Development of a new and kindly oral dosage form for elderly. JPST. 1997;13:251–8.
Yamamoto Y, Fujii M, Watanabe K, Tsukamoto M, Shibata Y, Kondoh M, et al. Effect of powder characteristics on oral tablet disintegration. Int J Pharm. 2009;365:116–20.
Sunada H, Bi YX. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol. 2002;122:188–98.
Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier Jp, Piccerelle Ph. Determination of the in-vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm. 2005;292:29–41.
Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139:94–107.
Goel H, Rai P, Rana V, Tiwary AK. Orally disintegrating systems: innovations in formulation and technology. Recent Patents on Drug Delivery and Formulation. 2008;2:258.
Mishra R, Amin A. Formulation development of taste-masked rapidly dissolving films of cetirizine hydrochloride. Pharmtech. 2009;33(2):48–56.
Pillai R, Karatgi P. Orally disintegrating tablets: the path to improved patient compliance and enhanced life cycle management. Pharmtech Europe. 2009;21(5):37–41.
Shimoda H, Taniguchi K, Nishimura M, Matsuura K, Tsukioka T, Yamashita H, et al. Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy. Eur J Pharm Sci. 2009;73:361–5.
Nishimura M, Matsuura K, Tsukioka T, Yamashita H, Inagaki N, Sugiyama T, et al. In vitro and in vivo characteristics of prochlorperazine oral disintegrating film. Int J Pharm. 2009;368:98–102.
Chambin O, Champion D, Debray C, Rochat-Gonthier MH, Le Meste M, Pourcelot Y. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J Control Release. 2004;95:101–8.
Yan YD, Jong SW, Kang JH, Yong CS, Choi HG. Preparation and evaluation of taste-masked donepezil hydrochloride orally disintegrating tablets. Biol Pharm Bull. 2010;33(8):1364–70.
Borsadia SB, O'Halloran D, Osborne JL. Quick-dissolving films—a novel approach to drug delivery. Drug development and delivery. 2003;3(3). Available online at http://www.drugdeliverytech.com/ME2/dirmod.asp?sid=&nm=&type=Publishing&mod=Publications%3A%3AArticle&mid=8F3A7027421841978F18BE895F87F791&tier=4&id=1462E9E570724362AF256AB9CEC63126.
Koh N, Sakamoto S, Chino F. Improvement in medication compliance and glycemic control with voglibose oral disintegrating tablet. Tohoku J Exp Med. 2008;216(3):249–57.
Bruce JK, Angela LH, Liu H, Sara KW. Olanzapine orally disintegrating tablet in the treatment of acutely ill non-compliant patients with schizophrenia. IJNP. 2003;6:97–102.
Raviraj P, Pradeep K. Orally disintegrating tablets: the path to improve patient compliance and enhanced life cycle management. Pharmtech Europe. 2009;21:5.
Emilio MC, Vincente GG, Albert NS, Jose PF, Joan HN, Jordi GC, et al. A study on the subjective compliance and acceptance of oral lanzoprazole in traumatology. The ECOFT-TR Study. Clin Rheumatol. 2009;5(2):49–54.
Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note. AAPS PharmSciTech. 2007;8(1):13.
Mishra R, Amin A. Manufacturing techniques of orally dissolving films. J Pharm Sci. 2011;35(1):70–3.
Pappa H, Farrú R, Vilanova PO, Palacios M, Pizzorno MT. A new HPLC method to determine donepezil hydrochloride in tablets. J Pharmaceut Biomed. 2002;27:177–82.
Japanese Pharmacopoeia 15. General tests, processes and apparatus. Tokyo, Japan: The Society of Japanese Pharmacopoeia. p. 107.
Cilurzo F, Cupone IE, Minghetti P, Selmin F, Montanari L. Fast dissolving films made of maltodextrins. Eur J Pharm Biopharm. 2008;70(3):895–900.
Kuno Y, Kojima M, Andoand S, Nakagami H. Effect of preparation method on properties of orally disintegrating tablets made by phase transition. Int J Pharm. 2008;355(1–2):87–92.
Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. p. 702.
Doe J. 2010 Sucralose—Technological Justification. www.food.gov.uk/multimedia/pdfs/sucraconsult2.pdf. Accessed26 Oct 2010.
Rowe R, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009. p. 48.
Bayarri S, Izquierdo L, Costell E. Sweetening power of aspartame in hydrocolloids gels: influence of texture. Food Hydrocolloids. 2007;21:1265–74.
Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London: Pharmaceutical Press; 2009.
Riera CE, Vogel H, Simon SA, Coutre Jl. Artificial sweeteners and salts producing a metallic taste sensation activate TRPV1 receptors. Am J Physiol. 2007;293:626–34.
Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S. A new formulation for orally disintegrating tablets using a suspension spray-coating method. Int J Pharm. 2009;382(1–2):80–7.
Chandrasekhar R, Hassan Z, AlHusban F, Smith AM, Mohammed AR. The role of formulation excipients in the development of lyophilised fast-disintegrating tablets. Eur J Pharm Biopharm. 2009;72:119–29.
Kearney P, Rathbone MJ, Hadgraft R. The Zydis oral fast-dissolving dosage form. Modified-Release Drug Delivery Technology. 2002;2:191–201.
Abdelbary G, Prinderre P, Eouani C, Joachim J, Reynier JP, Piccerelle Ph. The preparation of orally disintegrating tablets using a hydrophilic waxy binder. Int J Pharm. 2004;278:423–33.
Park TJ, Ko DH, Kim YJ, Kim YG. Polymorphic characterization of pharmaceutical solids, donepezil hydrochloride, by C CP/MAS solid-state nuclear magnetic resonance spectroscopy. B Kor Chem Soc. 2009;30(9):2007–10.
Krishna R, Moses JB, Anil K, Chandrashekar, Vijayavitthal T, Eswaraiah S, et al. Identification and characterization of potential impurities of donepezil. J Pharmaceut Biomed. 2004;35(5):1047–58.
ACKNOWLEDGEMENT
This author would like to thank Institute of Postgraduate Studies, Universiti Sains Malaysia for providing Fellowship.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guest Editors: Michael Repka, Joseph Reo, Linda Felton, and Stephen Howard
Rights and permissions
About this article
Cite this article
Liew, K.B., Tan, Y.T.F. & Peh, K.K. Characterization of Oral Disintegrating Film Containing Donepezil for Alzheimer Disease. AAPS PharmSciTech 13, 134–142 (2012). https://doi.org/10.1208/s12249-011-9729-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12249-011-9729-4